RxDoctor Payments Data

Ovidiu Batca

Internal Medicine · Lansing, MINPI 1093761967

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,561 and has fallen 88.2% since, to $184 in 2023.

$3,321in general payments, 2019–2025

Across 211 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$404
  • Amgen$310
  • Boehringer Ingelheim$289
  • Novo Nordisk$247
  • Biohaven Pharmaceutical Holding Company Ltd.$213
  • Lilly USA, LLC$174
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$3,321100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,321 in reported general payments places this provider in the 85th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan →

Other internal medicine in Lansing

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →